Nodal and Cripto-1 Signaling: Re-emergence in Cancer and Biological Role
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (30 June 2021) | Viewed by 14157
Special Issue Editor
Interests: cancer biomarkers; therapeutic targets
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The heterogeneous nature of cancer is exemplified by metastatic lesions that do not resemble the original primary cancer and by disease recurrence in patients that initially showed therapeutic response. The identification of stem-cell-like cancer cells (CSCs) that presumably generate the diverse progeny of cancer cells is thought to contribute to this heterogeneity. Thus, efforts continue towards identifying specific markers for detecting and targeting these CSCs. A more functional approach for clarifying the biological role of these CSCs is to study the re-emergence of embryonic signaling pathways in cancer. Nodal, a tumor growth factor-beta-related protein, and its co-receptor Cripto-1, a member of the epidermal growth factor-like family of proteins, are both important for embryonic development. Both these proteins are also re-expressed in different cancer types and have been shown to play a role in cancer progression, plasticity and transdifferentiation, and drug resistance. The aim of this Special Issue is to highlight some of the key findings that support the role of Nodal and Cripto-1 during these processes and how these results may be exploited for the development of novel biomarkers and therapeutic targets.
Dr. Luigi Strizzi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Nodal
- Cripto-1
- proliferation
- drug resistance
- biomarker
- therapeutic targets
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.